Author Index
Search or browse for an author across our entire electronic archive
Search results for: D
Results 921 - 930 of 1402 shown below
Dolo, V
A Ferretti, S D'Ascenzo, A Knijn, E Iorio, V Dolo, A Pavan and F Podo
Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a1H NMR study
doi:10.1038/sj.bjc.6600189
Abstract | Full article | PDF
Dolsma, W V
M Schaapveld, E G E de Vries, R Otter, J de Vries, W V Dolsma and P H B Willemse
Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
advance online publication, 2005-08-23 00:00:00.000;
doi:10.1038/sj.bjc.6602747
Abstract | Full article | PDF
Dolz˘an, V
M C˘emaz˘ar, D Miklavc˘ic˘, J S˘c˘anc˘ar, V Dolz˘an, R Golouh and G Sers˘a
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin
doi:10.1038/sj.bjc.6690222
Domènech, M
O Díez, A Osorio, M Robledo, A Barroso, M Domènech, J Cortés, J Albertos, J Sanz, J Brunet, J M SanRom´n, M C Alonso, M Baiget and J Benítez
Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients
doi:10.1038/sj.bjc.6690208
Dombernowsky, P
U N Lassen, K Østerlind, B Bergman, P Dombernowsky and H H Hansen
Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression
doi:10.1038/sj.bjc.6690080
-
J B Sørensen, B Bergman, M Krarup, P Dombernowsky and H H Hansen
Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer
doi:10.1038/sj.bjc.6690140
-
M K Tuxen, G Sölétormos and P Dombernowsky
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
doi:10.1054/bjoc.2001.1787
Domchek, S M
O M Sinilnikova, A C Antoniou, J Simard, S Healey, M Léoné, D Sinnett, A B Spurdle, J Beesley, X Chen, M H Greene, J T Loud, F Lejbkowicz, G Rennert, S Dishon, I L Andrulis, S M Domchek, K L Nathanson, S Manoukian, P Radice, I Konstantopoulou, I Blanco, A L Laborde, M Durán, A Osorio, J Benitez, U Hamann, F B L Hogervorst, T A M van Os, H J P Gille, S Peock, M Cook, C Luccarini, D G Evans, F Lalloo, R Eeles, G Pichert, R Davidson, T Cole, J Cook, J Paterson, C Brewer, D J Hughes, I Coupier, S Giraud, F Coulet, C Colas, F Soubrier, E Rouleau, I Bièche, R Lidereau, L Demange, C Nogues, H T Lynch, R K Schmutzler, B Versmold, C Engel, A Meindl, N Arnold, C Sutter, H Deissler, D Schaefer, U G Froster, K Aittomäki, H Nevanlinna, L McGuffog, D F Easton, G Chenevix-Trench and D Stoppa-Lyonnet
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
advance online publication, 2009-08-25 00:00:00.000;
doi:10.1038/sj.bjc.6605279
Abstract | Full article | PDF
-
A Osorio, R L Milne, G Pita, P Peterlongo, T Heikkinen, J Simard, G Chenevix-Trench, A B Spurdle, J Beesley, X Chen, S Healey, S L Neuhausen, Y C Ding, F J Couch, X Wang, N Lindor, S Manoukian, M Barile, A Viel, L Tizzoni, C I Szabo, L Foretova, M Zikan, K Claes, M H Greene, P Mai, G Rennert, F Lejbkowicz, O Barnett-Griness, I L Andrulis, H Ozcelik, N Weerasooriya, A-M Gerdes, M Thomassen, D G Cruger, M A Caligo, E Friedman, B Kaufman, Y Laitman, S Cohen, T Kontorovich, R Gershoni-Baruch, E Dagan, H Jernström, M S Askmalm, B Arver, B Malmer, S M Domchek, K L Nathanson, J Brunet, T Ramón y Cajal, D Yannoukakos, U Hamann, F B L Hogervorst, S Verhoef, EB Gómez García, J T Wijnen, A van den Ouweland, D F Easton, S Peock, M Cook, C T Oliver, D Frost, C Luccarini, D G Evans, F Lalloo, R Eeles, G Pichert, J Cook, S Hodgson, P J Morrison, F Douglas, A K Godwin, O M Sinilnikova, L Barjhoux, D Stoppa-Lyonnet, V Moncoutier, S Giraud, C Cassini, L Olivier-Faivre, F Révillion, J-P Peyrat, D Muller, J-P Fricker, H T Lynch, E M John, S Buys, M Daly, J L Hopper, M B Terry, A Miron, Y Yassin, D Goldgar, C F Singer, D Gschwantler-Kaulich, G Pfeiler, A-C Spiess, Thomas v O Hansen, O T Johannsson, T Kirchhoff, K Offit, K Kosarin, M Piedmonte, G C Rodriguez, K Wakeley, J F Boggess, J Basil, P E Schwartz, S V Blank, A E Toland, M Montagna, C Casella, E N Imyanitov, A Allavena, R K Schmutzler, B Versmold, C Engel, A Meindl, N Ditsch, N Arnold, D Niederacher, H Dei
ler, B Fiebig, R Varon-Mateeva, D Schaefer, U G Froster, T Caldes, M de la Hoya, L McGuffog, A C Antoniou, H Nevanlinna, P Radice and J BenítezEvaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
advance online publication, 2009-11-17 00:00:00.000;
doi:10.1038/sj.bjc.6605416
Domenech, M
J Carles, A Font, B Mellado, M Domenech, E Gallardo, J L González-Larriba, G Catalan, J Alfaro, A Gonzalez del Alba, M Nogué, P Lianes and J M Tello
Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study
advance online publication, 2007-10-23 00:00:00.000;
doi:10.1038/sj.bjc.6604030
Abstract | Full article | PDF
Domenge, C
C Couteau, N Chouaki, S Leyvraz, D Oulid-Aissa, A Lebecq, C Domenge, V Groult, S Bordessoule, F Janot, M De Forni and J-P Armand
A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
doi:10.1038/sj.bjc.6690715
-
C Domenge, C Hill, J L Lefebvre, D De Raucourt, B Rhein, P Wibault, P Marandas, B Coche-Dequeant, M Stromboni-Luboinski, H Sancho-Garnier and B Luboinski
Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma
doi:10.1054/bjoc.2000.1512
Domenichini, I
F Cappuzzo, L Toschi, I Domenichini, S Bartolini, G L Ceresoli, E Rossi, V Ludovini, A Cancellieri, E Magrini, L Bemis, W A Franklin, L Crino, P A Bunn, F R Hirsch and M Varella-Garcia
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients
advance online publication, 2005-11-15 00:00:00.000;
doi:10.1038/sj.bjc.6602865
Abstract | Full article | PDF
Domingo-Domenech, J
J Domingo-Domenech, B Mellado, B Ferrer, D Truan, J Codony-Servat, S Sauleda, J Alcover, E Campo, P Gascon, A Rovira, J S Ross, P L Fernández and J Albanell
Activation of nuclear factor-
B in human prostate carcinogenesis and association to biochemical relapseadvance online publication, 2005-11-08 00:00:00.000;
doi:10.1038/sj.bjc.6602851
Abstract | Full article | PDF
-
Result page:
- 1|
- 2|
- 3|
- 4|
- 5|
- 6|
- 7|
- 8|
- 9|
- 10|
- 11|
- 12|
- 13|
- 14|
- 15|
- 16|
- 17|
- 18|
- 19|
- 20|
- 21|
- 22|
- 23|
- 24|
- 25|
- 26|
- 27|
- 28|
- 29|
- 30|
- 31|
- 32|
- 33|
- 34|
- 35|
- 36|
- 37|
- 38|
- 39|
- 40|
- 41|
- 42|
- 43|
- 44|
- 45|
- 46|
- 47|
- 48|
- 49|
- 50|
- 51|
- 52|
- 53|
- 54|
- 55|
- 56|
- 57|
- 58|
- 59|
- 60|
- 61|
- 62|
- 63|
- 64|
- 65|
- 66|
- 67|
- 68|
- 69|
- 70|
- 71|
- 72|
- 73|
- 74|
- 75|
- 76|
- 77|
- 78|
- 79|
- 80|
- 81|
- 82|
- 83|
- 84|
- 85|
- 86|
- 87|
- 88|
- 89|
- 90|
- 91|
- 92|
- 93|
- 94|
- 95|
- 96|
- 97|
- 98|
- 99|
- 100|
- 101|
- 102|
- 103|
- 104|
- 105|
- 106|
- 107|
- 108|
- 109|
- 110|
- 111|
- 112|
- 113|
- 114|
- 115|
- 116|
- 117|
- 118|
- 119|
- 120|
- 121|
- 122|
- 123|
- 124|
- 125|
- 126|
- 127|
- 128|
- 129|
- 130|
- 131|
- 132|
- 133|
- 134|
- 135|
- 136|
- 137|
- 138|
- 139|
- 140|
- 141|
- Next
